lncRNA-PRLB Confers Paclitaxel Resistance of Ovarian Cancer Cells by Regulating RSF1/NF-κB Signaling Pathway

Background: Long noncoding RNA (lncRNA)-PRLB (progression-associated lncRNA in breast cancer) has been identified to enhance the drug resistance of breast cancer cells. In this study, the authors explored PRLB effect in the paclitaxel (Tax) resistance of ovarian cancer cells and revealed the role of RSF1 (remodeling and spacing factor 1)/nuclear factor kappaB (NF-κB) signaling in this process. Materials and Methods: Tax resistance was...